NCT07007702View on ClinicalTrials.gov

Anti-inflammatory Effects and Clinical Efficacy of Topical Thealoz Total Eye Drops in Patients With Chronic Dry Eye Disease

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

January 27, 2025

Primary Completion Date

April 28, 2025

Study Completion Date

June 30, 2025

Conditions
Dry Eye Disease (DED)
Interventions
DEVICE

T2769

Preservative-free combination of trehalose, sodium hyaluronate and N-Acetyl Aspartyl Glutamic Acid

Trial Locations (1)

Unknown

Universitätsklinik für Klinische Pharmakologie, Allgemeines Krankenhaus Wien, Vienna

Sponsors

Lead Sponsor

Laboratoires Thea
All Listed Sponsors
lead

Laboratoires Thea

INDUSTRY

NCT07007702 - Anti-inflammatory Effects and Clinical Efficacy of Topical Thealoz Total Eye Drops in Patients With Chronic Dry Eye Disease | Biotech Hunter | Biotech Hunter